Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tackley, G."" wg kryterium: Autor


Tytuł :
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Autorzy :
Jurynczyk M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.; Department of Neurology, Medical University of Lodz, Lodz, Poland.
Probert F; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. .
Yeo T; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK.; Department of Neurology, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
Tackley G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Claridge TDW; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.
Cavey A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Woodhall MR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Arora S; Mathematical Institute, University of Oxford, Woodstock Rd, Oxford, OX2 6GC, UK.
Winkler T; Numares AG, Am Biopark 9, 93053, Regensburg, Germany.
Schiffer E; Numares AG, Am Biopark 9, 93053, Regensburg, Germany.
Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
DeLuca G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Sibson NR; Cancer Research UK & Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, OX37DQ, Oxford, UK.
Isabel Leite M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Waters P; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK.
Anthony DC; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK. .
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 3, West Wing, Headley Way, Oxford, OX3 9DU, UK. .
Pokaż więcej
Źródło :
Acta neuropathologica communications [Acta Neuropathol Commun] 2017 Dec 06; Vol. 5 (1), pp. 95. Date of Electronic Publication: 2017 Dec 06.
Typ publikacji :
Journal Article
MeSH Terms :
Aquaporin 4/*immunology
Autoantibodies/*blood
Metabolomics/*methods
Multiple Sclerosis, Relapsing-Remitting/*metabolism
Myelin-Oligodendrocyte Glycoprotein/*immunology
Neuromyelitis Optica/*metabolism
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Lipoproteins/classification ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Neuromyelitis Optica/diagnosis ; Neuromyelitis Optica/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Autorzy :
Jurynczyk M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Messina S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Woodhall MR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Raza N; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Everett R; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Roca-Fernandez A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Tackley G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Hamid S; NMO Clinical Service, The Walton Centre, Liverpool, UK.
Sheard A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Reynolds G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Chandratre S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Hemingway C; Department of Neurology, Great Ormond Street Hospital for Children, London, UK.
Jacob A; NMO Clinical Service, The Walton Centre, Liverpool, UK.
Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Leite MI; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Waters P; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2017 Dec 01; Vol. 140 (12), pp. 3128-3138.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Autoantibodies/*blood
Myelin-Oligodendrocyte Glycoprotein/*blood
Neuromyelitis Optica/*blood
Neuromyelitis Optica/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Cohort Studies ; Disabled Persons ; Female ; Humans ; Infant ; Male ; Middle Aged ; Neuromyelitis Optica/diagnosis ; Prognosis ; United Kingdom/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Autorzy :
Jurynczyk M; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Geraldes R; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Probert F; Department of Pharmacology, University of Oxford, Oxford, UK.
Woodhall MR; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Waters P; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Tackley G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
DeLuca G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Chandratre S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Leite MI; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Vincent A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Palace J; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2017 Mar 01; Vol. 140 (3), pp. 617-627.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Central Nervous System Diseases*/immunology
Central Nervous System Diseases*/metabolism
Aquaporin 4/*immunology
Autoantibodies/*metabolism
Brain/*diagnostic imaging
Multiple Sclerosis/*diagnostic imaging
Myelin-Oligodendrocyte Glycoprotein/*immunology
Adolescent ; Adult ; Age Factors ; Child ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/immunology ; Multiple Sclerosis/metabolism ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/metabolism ; Principal Component Analysis ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies